Circ_0001741 exerts as a tumor promoter in ovarian cancer through the regulation of miR-491-5p/PRSS8 axis

被引:0
|
作者
Wang, Ding [1 ]
Zhang, Sumin [1 ]
Wang, Qiaoling [1 ]
Li, Pengrong [1 ]
Liu, Yunxia [1 ]
机构
[1] Yi Chang Maternal & Child Hlth Hosp, Dept Gynaecol, 99 Chengdong Ave, Yichang 443001, Hubei, Peoples R China
关键词
Ovarian cancer; Circ_0001741; MiR-491-5p; PRSS8; CELL-PROLIFERATION; MIGRATION; INVASION;
D O I
10.1007/s12672-024-01474-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundCircular RNAs (circRNAs) are important regulators for ovarian cancer (OC). Circ_0001741 has been found to be highly expressed in OC samples and is involved in regulating paclitaxel resistance in OC cells. Therefore, circ_0001741 may play a vital role in OC process, and its potential molecular mechanism is worth further revealing.MethodsCirc_0001741, miR-491-5p, and PRSS8 levels in OC tumor tissues and cells were quantified by quantitative real-time PCR or western blot. The proliferation, apoptosis and metastasis of OC cells were detected by cell counting kit 8 assay, Edu assay, flow cytometry, and transwell assay. RNA interaction was verified by dual-luciferase reporter assay and RIP assay. Xenograft assay was used to detect the effect of circ_0001741 knockdown on OC tumor growth in vivo.ResultsCirc_0001741 was upregulated in OC tissues and cell lines. Knockdown of circ_0001741 repressed OC cell proliferation, metastasis, and enhanced apoptosis. Mechanistically, miR-491-5p was targeted by circ_0001741, and miR-491-5p inhibitor could attenuate the effect of circ_0001741 silencing on OC cell progression. Meanwhile, PRSS8 was a target of miR-491-5p, and miR-491-5p overexpression inhibited OC cell progression by targeting PRSS8. Circ_0001741 regulated PRSS8 expression by sponging miR-491-5p. Besides, circ_0001741 knockdown also inhibited OC tumor growth in vivo.ConclusionOur data showed that circ_0001741 could promote the growth and metastasis of OC cells through the miR-491-5p/PRSS8 axis, which provided a potential molecular target for the treatment of OC.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis
    Enjian Guan
    Hongrong Liu
    Ning Xu
    Digestive Diseases and Sciences, 2022, 67 : 2244 - 2256
  • [32] Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis
    Guan, Enjian
    Liu, Hongrong
    Xu, Ning
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2244 - 2256
  • [33] circ_0039787 promotes cervical cancer cell tumorigenesis by regulation of the miR-877-5p-KRAS axis
    He, Xiuchao
    Sun, Jing
    Zhang, Jing
    Zhu, Binbin
    Jin, Lufei
    Wang, Jianhua
    Guan, Qingyan
    AGING-US, 2024, 16 (03): : 2736 - 2752
  • [34] LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis
    Qi, Guanbin
    Li, Lei
    ONCOTARGETS AND THERAPY, 2020, 13 : 6361 - 6371
  • [35] Circ_0015756 promotes ovarian cancer progression via the miR-145-5p/PSAT1 axis
    Pan, Yizhen
    Huang, Qianyu
    Peng, Xiaodan
    Yu, Shaokang
    Liu, Nannan
    REPRODUCTIVE BIOLOGY, 2022, 22 (04)
  • [36] hsa_circ_0000129 targets miR-383-5p/tropomyosin 3 axis to facilitate ovarian cancer progression
    Li, Yuan
    Liu, Can
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2024,
  • [37] LINC02532 by Mediating miR-541-3p/HMGA1 Axis Exerts a Tumor Promoter in Breast cancer
    Zhao, Chunming
    Li, Xiao
    Pan, Xueqiang
    Xu, Jiawen
    Jiang, Rui
    Li, Yuyang
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (01) : 196 - 208
  • [38] Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis
    Changqiao Ju
    Jia Zhou
    Hui Miao
    Xin Chen
    Qingyu Zhang
    BMC Anesthesiology, 20
  • [39] Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis
    Ju, Changqiao
    Zhou, Jia
    Miao, Hui
    Chen, Xin
    Zhang, Qingyu
    BMC ANESTHESIOLOGY, 2020, 20 (01)
  • [40] MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression
    Zheng, J.
    Zhou, Y.
    Li, X-J
    Hu, J-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (16) : 6839 - 6848